This review article aims at discussing the potential of therapeutic GLP-1 receptor agonists in alleviating depressive symptoms in the context of modern theories surrounding the pathogenesis of this disease and explores their influence on cognitive processes, neurotransmission, modulation of neuroinflammatory processes, effects on HPA axis activity, brain energy balance, and the functioning of the gut-brain axis
Decreased Appetite: While this can be beneficial for weight loss, some individuals may experience a decrease in appetite that can be more pronounced than expected
This depends on your medication regimen, whether you hold a group 1 or group 2 licence and other individualised factors
The COA documents purity (HPLC), molecular identity (mass spectrometry), and testing methodology
Therefore, slow titration and following your healthcare providers dosage schedule can help you reduce the intensity and duration of the symptoms